Treatment and clinical outcome in patients with basilar artery occlusion [8]

Stroke

Volumn 37, Issue 9, 2006, Pages 2206-

  Schonewille, Wouter ^a   Wijman, Christine ^b   Michel, Patrik ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Stanford California and Cofounder   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ARTERY OCCLUSION; BASILAR ARTERY; BLOOD CLOT LYSIS; CLINICAL TRIAL; HEALTH CENTER; HUMAN; LETTER; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RADIOLOGY; TREATMENT OUTCOME;

ARTERIAL OCCLUSIVE DISEASES; BASILAR ARTERY; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; TREATMENT OUTCOME;

EID: 33748353400     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000237127.84408.c0     Document Type: Letter

References (2)

1. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion. A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37:922-928.
2. Schonewille WJ, Algra A, Serena J, Molina C, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005;76:1238-1241.